Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Cambridge, Business
Sage Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023 Cambridge, Business
Forrester Research To Broadcast Its 2022 Fourth-Quarter And Full-Year Earnings Conference Call Cambridge, Business
"Third Thursdays"w/host Bryant (keys), Jones (drums), Hopkins (tpt), Moltoni (gui), Lockwood (bass) Cambridge
Nathaniel Rateliff & The Night Sweats To Headline Forrester's 2023 B2B Summit North America Cambridge, Business
Sesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connection with Pending Merger with Carisma Therapeutics Cambridge, Business
Amylyx Pharmaceuticals Announces Exclusive AMX0035 Distribution Agreement with Israel-Based Neopharm Cambridge, Business
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Cambridge, Business
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2022 Global Net Product Revenues and Provides Additional Updates Cambridge, Business
Harmolodic jazzer Dave Bryant announces his mid-winter "Third Thursdays" monthly concert lineup Cambridge
Sage Therapeutics to Provide Update on 2023 Key Initiatives at 41st Annual J.P. Morgan Healthcare Conference Cambridge, Business
Apnimed Completes Oversubscribed $79.75 Million Series C Extension Financing to Fund Two Planned Phase 3 Trials of AD109, an Oral Medication with the Potential to Be the First Therapy for Direct Treatment of Obstructive Sleep Apnea (OSA) Cambridge, Business
Quantori Partners with Databricks to Accelerate Data-Driven Innovation in the Life Sciences and Healthcare Industries Cambridge, Business